INTRODUCTION: African Americans are less likely than other racial/ethnic groups to receive appropriate surveillance, an important component of care to achieve better long-term outcomes and well-being after colorectal cancer (CRC) treatment. This study explored survivors' understanding of surveillance instructions and purpose. PATIENTS AND METHODS: Interviews with 60 African American CRC survivors were recorded and transcribed. Compliance with surveillance guidelines was defined by disease stage and self-reported tests. Four coders (blind to compliance status) independently reviewed transcripts. Frequency of themes was reported by compliance status. RESULTS: Survivors (4 to 6 years postdiagnosis; women, 57%; age ≥ 65 years, 60%; rural location, 57%; early-stage disease, 62%) were 48% noncompliant. Most survivors reported receiving surveillance instructions from providers (compliant, 80%; noncompliant, 76%). There was variation in recommended frequency of procedures (eg, every 3 or 12 months) and in importance of surveillance stressed by physicians. Most survivors understood the need for follow-up (compliant, 87%; noncompliant, 79%). Lack of knowledge of/interest in surveillance was more common among noncompliant individuals (compliant, 32%; noncompliant, 52%). CONCLUSION: Patients' limited understanding about the importance of CRC surveillance and procedures may negatively affect compliance with recommendations in African American CRC survivors. Clear and enhanced communications about post-treatment recommendations in this population are warranted.
INTRODUCTION: African Americans are less likely than other racial/ethnic groups to receive appropriate surveillance, an important component of care to achieve better long-term outcomes and well-being after colorectal cancer (CRC) treatment. This study explored survivors' understanding of surveillance instructions and purpose. PATIENTS AND METHODS: Interviews with 60 African American CRC survivors were recorded and transcribed. Compliance with surveillance guidelines was defined by disease stage and self-reported tests. Four coders (blind to compliance status) independently reviewed transcripts. Frequency of themes was reported by compliance status. RESULTS: Survivors (4 to 6 years postdiagnosis; women, 57%; age ≥ 65 years, 60%; rural location, 57%; early-stage disease, 62%) were 48% noncompliant. Most survivors reported receiving surveillance instructions from providers (compliant, 80%; noncompliant, 76%). There was variation in recommended frequency of procedures (eg, every 3 or 12 months) and in importance of surveillance stressed by physicians. Most survivors understood the need for follow-up (compliant, 87%; noncompliant, 79%). Lack of knowledge of/interest in surveillance was more common among noncompliant individuals (compliant, 32%; noncompliant, 52%). CONCLUSION:Patients' limited understanding about the importance of CRC surveillance and procedures may negatively affect compliance with recommendations in African American CRC survivors. Clear and enhanced communications about post-treatment recommendations in this population are warranted.
Authors: Ramzi G Salloum; Mark C Hornbrook; Paul A Fishman; Debra P Ritzwoller; Maureen C O'Keeffe Rossetti; Jennifer Elston Lafata Journal: Cancer Date: 2012-03-20 Impact factor: 6.860
Authors: Christopher E Desch; Al B Benson; Mark R Somerfield; Patrick J Flynn; Carol Krause; Charles L Loprinzi; Bruce D Minsky; David G Pfister; Katherine S Virgo; Nicholas J Petrelli Journal: J Clin Oncol Date: 2005-10-31 Impact factor: 44.544
Authors: Talya Salz; Noel T Brewer; Robert S Sandler; Bryan J Weiner; Christopher F Martin; Morris Weinberger Journal: J Cancer Surviv Date: 2009-09-16 Impact factor: 4.442
Authors: Samuel G Smith; Christian von Wagner; Lesley M McGregor; Laura M Curtis; Elizabeth A H Wilson; Marina Serper; Michael S Wolf Journal: Dis Colon Rectum Date: 2012-10 Impact factor: 4.585
Authors: Jennifer L Malin; Clifford Ko; John Z Ayanian; David Harrington; David R Nerenz; Katherine L Kahn; Julie Ganther-Urmie; Paul J Catalano; Alan M Zaslavsky; Robert B Wallace; Edward Guadagnoli; Neeraj K Arora; Maryse D Roudier; Patricia A Ganz Journal: Support Care Cancer Date: 2006-02-16 Impact factor: 3.603
Authors: Durado D Brooks; Sidney J Winawer; Douglas K Rex; Ann G Zauber; Charles J Kahi; Robert A Smith; Bernard Levin; Richard Wender Journal: Am Fam Physician Date: 2008-04-01 Impact factor: 3.292
Authors: Julia R Berian; Amanda Cuddy; Amanda B Francescatti; Linda O'Dwyer; Y Nancy You; Robert J Volk; George J Chang Journal: J Cancer Surviv Date: 2017-06-22 Impact factor: 4.442
Authors: Lisa M Lowenstein; Robert J Volk; Amanda Cuddy; Andrea P Hempstead; Y Nancy You; Katherine Van Loon; Stefanos Millas; Jeffrey A Meyerhardt; Patrick Gavin; George J Chang Journal: BMJ Open Date: 2019-08-15 Impact factor: 2.692
Authors: Marvella E Ford; Katherine R Sterba; Kent Armeson; Angela M Malek; Kendrea D Knight; Jane Zapka Journal: J Cancer Educ Date: 2019-10 Impact factor: 1.771